Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong General Pharmaceutical Co., Ltd., a subsidiary of China Meheco Group, is a comprehensive pharmaceutical manufacturer based in Nantong, China. Founded in 1958, the company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms across various therapeutic areas, including anti-infectives, cardiovascular diseases, and digestive system disorders. The company operates large-scale manufacturing facilities that comply with international GMP standards, exporting products to numerous global markets. Its portfolio includes key products such as clindamycin hydrochloride and various antibiotic formulations. Nantong General Pharmaceutical plays a significant role in the Chinese pharmaceutical supply chain, leveraging its integration within the China Meheco network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong General Pharmaceutical.